Anavex Life Sciences Corp (AVXL)

[falconer66a]

NOT easy (for the untrained) to believe.

Why are you saying this when ANAVEX has explained it in simple terms since 2015? Very easy to understand. It is as ANAVEX has explained it!

Well, that substantiates my contention.

Yes, indeed, Anavex has very thoroughly explained the blarcamesine mechanism of action (MOA), along with data from Phase 1 and 2 clinical trial outcomes of wonderful safety and efficacies.

And, yes, it is as Anavex has explained it. But market forces don’t believe it; haven’t yet decided to act on all of what Anavex has revealed. Anyone, a retail equity investor, or an institution can spend an afternoon scrutinizing all of the data on the Anavex webpages. The company isn’t hiding anything; it’s all laid out in the charts and graphics. But, so far, without Phase 3 clinical trial readouts, very few believe that the preliminary data will result in positive Phase 3 outcomes. They are going to wait to see; not ready to make any AVXL commitment from what they see in the existing data.